Options
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease
Fecha de emisión
2015
Autor(es)
DOI
10.3389/fnagi.2014.00340
Temas
Akt(PKB)
Beta-amyloid
Cotinine
Nicotine
Parkinson disease
Synucleinopathies
3 (2,4 dimethoxybenzy...
cotinine
drug metabolite
nicotine
dopaminergic nerve ce...
drug effect
drug safety
human
memory
motor performance
nerve cell plasticity...
nervous system inflam...
nonhuman
oxidative stress
Parkinson disease
protein aggregation
Review
Archivo(s)